Page last updated: 2024-08-23

vindesine and Congenital Thrombotic Thrombocytopenic Purpura

vindesine has been researched along with Congenital Thrombotic Thrombocytopenic Purpura in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Brunot, A; Issler, M; Ojeda-Uribe, M	1

Other Studies

1 other study(ies) available for vindesine and Congenital Thrombotic Thrombocytopenic Purpura

Article	Year
[Successful treatment of idiopathic acquired refractory thrombotic thrombocytopenic purpura with an association of rituximab-vindesine. Report of one case]. Revista medica de Chile, 2005, Volume: 133, Issue:11 Topics: ADAM Proteins; ADAMTS13 Protein; Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents, Phytogenic; Drug Therapy, Combination; Female; Humans; Immunologic Factors; Platelet Transfusion; Purpura, Thrombocytopenic, Idiopathic; Purpura, Thrombotic Thrombocytopenic; Recurrence; Rituximab; Treatment Outcome; Vindesine; von Willebrand Factor	2005

Article

Year

[Successful treatment of idiopathic acquired refractory thrombotic thrombocytopenic purpura with an association of rituximab-vindesine. Report of one case].

Revista medica de Chile, 2005, Volume: 133, Issue:11

Topics: ADAM Proteins; ADAMTS13 Protein; Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents, Phytogenic; Drug Therapy, Combination; Female; Humans; Immunologic Factors; Platelet Transfusion; Purpura, Thrombocytopenic, Idiopathic; Purpura, Thrombotic Thrombocytopenic; Recurrence; Rituximab; Treatment Outcome; Vindesine; von Willebrand Factor

2005